As a critical enzyme participating in de novo DNA methylation, DNMT3B is thought to silence tumor suppress genes by methylating cytosine sites in gene promoters during the early stages of lung cancer development [21, 40]. The gene discussed is DNMT3B; the disease is lung carcinoma.